Author

K. Bahl

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:multiome· 1 Organism:non-human primate· 1

Frequent Co-Authors

A. Carfi· 2 shared C. J. Hsiao· 2 shared W.-P. Kong· 2 shared A. Bukreyev· 1 shared A. Cadete· 1 shared A. Golding· 1 shared A. J. Combes· 1 shared A. Jeon· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Carfi

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection

G. Baldeon Vaca, M. Meyer, A. Cadete, C. J. Hsiao, A. Golding, A. Jeon, E. Jacquinet, E. Azcue, C. M. Guan, X. Sanchez-Felix, C. A. Pietzsch, C. E. Mire, M. A. Hyde, M. E. Comeaux, J. M. Williams, , K. Bahl

This study shows intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 by inducing antibodies and reducing viral load and lung damage.

bioRxiv · Jan 11, 2023 · PreprintImmunology

An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection

B. A. Bollman, N. Nunna, K. Bahl, C. J. Hsiao, H. Bennett, S. Butler, B. Foreman, K. E. Burgomaster, M. Aleshnick, W.-P. Kong, B. E. Fisher, T. J. Ruckward, K. M. Morabito, B. S. Graham, K. A. Dowd, , A. Carfi

This study compares two ZIKV mRNA vaccines, showing that mRNA-1893 provides complete protection at a lower dose than mRNA-1325 in non-human primates.

bioRxiv · Oct 11, 2022 · PreprintImmunology

SARS-CoV-2 infection studies in lung organoids identify TSPAN8 as novel mediator

L. Hysenaj, S. Little, K. R. Kulhanek, O. Gbenedio, L. Rodriguez, A. Shen, J.-C. Lone, L. C. Lupin-Jimenez, L. Bonser, N. K. Serwas, K. Bahl, E. Mick, J. Z. Li, V. Ding, S. Matsumoto, , J. P. Roose

The paper identifies TSPAN8 as a novel mediator of SARS-CoV-2 infection in lung organoids, showing its correlation with infection rates and susceptibility to blocking antibodies.

bioRxiv · Jun 1, 2021 · PreprintMicrobiology

SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness

K. S. Corbett, D. Edwards, S. R. Leist, O. M. Abiona, S. Boyoglu-Barnum, R. A. Gillespie, S. Himansu, A. Schafer, C. T. Ziwawo, A. T. DiPiazza, K. H. Dinnon, S. M. Elbashir, C. A. Shaw, A. Woods, E. J. Fritch, , Wang

This paper describes the development of an mRNA vaccine (mRNA-1273) against SARS-CoV-2, showing it induces neutralizing antibodies and CD8 T cell responses and protects mice from infection.

bioRxiv · Jun 11, 2020Immunology

Near-atomic structures of the BBSome reveal a novel mechanism for transition zone crossing

K. Bahl, S. Yang, H.-T. Chou, J. Woodsmith, U. Stelzl, T. Walz, M. V. Nachury

The paper reveals how the BBSome facilitates GPCR transport across the transition zone by extracting amphipathic helices from the inner leaflet of the membrane.

bioRxiv · Jan 29, 2020Cell Biology